REN and diabetic kidney disease: Diabetic kidney disease (DKD) is the main cause of end-stage renal disease (ESRD) and, alongside drugs inhibiting the renin–angiotensin–aldosterone (RAAS) system and statins, novel pharmacological agents have recently been proposed to target renal disease in diabetes.